(Q53335798)

English

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity.

scientific article published in April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

High-dose chemotherapy and autologous haematopoietic support in poor risk non-seminomatous germ-cell tumours: an effective first-line therapy with minimal toxicity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

1 reference

based on heuristic

inferred from title

author name string

M P Decatris

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

P M Wilkinson

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

R S Welch

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

M Metzner

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

G R Morgenstern

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

M Dougall

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

427-434

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor-risk germ cell tumors. Recent developments.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: The Spanish Germ-Cell Cancer Group experience (GG)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment for poor prognosis metastatic germ-cell tumours: much heat but, as yet, little light

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008393512723

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008393512723

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/10847461

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53335798&oldid=1629261432"